Investor Presentaiton

Financial Matters As of June 30, 2021, no debt and $21.3 million of cash, cash equivalents and restricted cash Subsequent to Q2, closed sale of Flashtalking resulting in $44mm cash to Safeguard Safeguard expects to return value to shareholders as additional exits occur above targeted liquidity level . In Q1 2021, announced a reduction to the targeted liquidity threshold from $20 million to $18 million In May, Safeguard's Board of Directors authorized a new $6 million share repurchase program In Sept, Safeguard launched $35 million self-tender of its common stock in a modified Dutch auction at prices between (and including) $7.90 and $9.00 Follow-on funding to support companies declining: $9.2 million in 2020; target of $5-7mm 2021 Year-to-date 2021 of $1 million Compared to $17 million in 2019 and $16 million in 2018 Continuing to reduce corporate expenses*: $1.0 million for the quarter ended June 30, 2021 as compared to $1.2 million for comparable 2020 quarter Corporate expenses down 23% compared to Q2 2020 Expect to be below our initial 2021 target of $4.4 to $4.9 million Safeguard has ~$362 million of Tax NOLs & Carryforwards Management and Board compensation aligned with shareholders' interest • Board compensation is 100% equity . Board size reduced to 4 Directors in May 2020 Management compensation weighted to equity and performance * Corporate expense is a non-GAAP measure that represents general and administrative expenses excluding depreciation, stock-based compensation, severance and retirement costs, and other non-recurring items. G www.safeguard.com SFE © 2021 Safeguard Scientifics, Inc. All rights reserved. LISTED NYSE 7

View entire presentation